VERRICA PHARMACEUTICALS INC
VRCA·92511W207·US·Common Stock·Healthcare - Biotechnology-Activist
VRCA (VERRICA PHARMACEUTICALS INC) is held by 22 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($998,530), MARSHALL WACE, LLP ($743,229), GEODE CAPITAL MANAGEMENT, LLC ($734,965). Net institutional sentiment: Mixed.
22
Holders
Avg rating(5 Elite)
$4.7M
Total Value
52% (33)
Fund Consensus
14 buying - 13 selling
Who's Trading
ActivistARArmistice Capital, LLC5.0%Feb 17, 2026
ActivistAAAffinity Asset Advisors, LLC5.5%Jan 29, 2026
ActivistCACaligan Partners LP10.0%Dec 30, 2025
ActivistPBPaul B Manning49.9%Nov 28, 2025
InsiderMBManning Paul BBuy $5.8MNov 25, 2025
InsiderMBManning Paul BBuy $11.7MNov 25, 2025
InsiderRJRieger JaysonBuy $400KNov 25, 2025
InsiderZDZawitz DavidBuy $42KNov 25, 2025
InsiderKJKirby John J.Buy $15KNov 25, 2025
InsiderRLRosenberg Noah L.Buy $10KNov 25, 2025
13F: Insider & Congress:
Showing 1-20 of 33
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer